HG-1124

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameHG-1124

Drug Alias NameB3GALT3 modulator (Human Genome Sciences)BETA-3-GALT3 modulator(Human Genome Sciences)GLCT3 modulator (Human Genome Sciences)gb4 synthase (Human Genome Sciences)glob (Human Genome Sciences) +[13]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionImmunomodulatorsNeuroprotectants

TargetsUpdating

Therapy Area/IndicationsImmune System DiseasesNervous System DiseasesNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesHuman Genome Sciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHuman Genome Sciences Inc

Active IndicationsN/A

Inactive IndicationsImmune System DiseasesNervous System DiseasesNeoplasms

Other Information

ATC CodeN/A